Exam 4 vocab Flashcards
How do you measure a drug’s potency?
ED50 or EC50
How do you measure a drug’s efficacy?
Emax
Occupancy theory
the response is directly proportional to the number of drug-receptor complexes formed
Agonist
binds to a receptor and elicits a response
Intrinsic activity
the capacity of a drug molecule to activate transduction as a function of binding to its receptor
Full agonist
a drug that causes the maximal response observed in a system. Efficacy is equal to 1 or 100%
Partial agonist
a drug that fails to cause the maximal response even when all receptors are bound. Intrinsic activity and efficacy are less than 1
Inverse agonist
a drug that causes an effect opposite of a ‘typical’ agonist; you lose basal activity and major upregulation results because all receptors are stabilized in the inactive form. Efficacy and intrinsic activity are less than 0. These are most obvious in a system with a high level of basal activity in absence of a drug.
Antagonist
a drug that upon binding to a receptor has no effect - doesn’t change the basal activity. Efficacy and intrinsic activity are 0.
Two state receptor theory
most receptors are limited to two states - off and on
Multi-state receptor theory
different agonists cause different activity
Summation of agonists
the effect of two agonists in combination is the predicted sum of the effect of each in isolation. The agonists may nor may not
Potentation
the effect of one agonist in combination with an ineffective drug is greater than the effect of the agonist by itself. The two drugs must be acting by different mechanisms - the compound causing the effect doesn’t even have to be a drug. An example is CYP induction/inhibition.
Allosteric agonist
bind to a different site on the receptor than a full agonist and elicit an effect
Chemical antagonist
chelation
Physiologic antagonist
a drug that acts at a different receptor site (agonist at this site) to cause an effect that is opposite of an agonist in the system. These two agonists act together to cancel each other out
Difference between an physiologic antagonist and an inverse agoninst
a physiologic antagonist is on a different receptor site and an inverse agonist acts on the same receptor site
Pharmacological antagonist
binds receptors and does not cause a response, but blocks agonist-receptor interactions
Mixed agonist/antagonist
a drug that has different effects at different receptor subtypes
Selective response modulator
a drug that has different effects at the same receptor subtypes in different tissue types
Spare receptors
some full agonists only bind to a fraction of the receptors yet elicit a full response. Spare receptors occur because the signal transduction proteins are limiting
Threshold of Toxicological Concern
a concept that is used when there is no chemical-specific data. We assume there is no appreciable risk to human health based on the chemical structure and level of exposure
acute exposure
single event/dose - monitored for 14 days; 3 doses
sub-acute exposure
14 days - 14 doses repeating the same dose
90 day chronic exposure
repeated dose for 90 days; study will usually be set up with 3 doses. Animals are monitored for signs of sickness, organs and tissues evaluated by a pathologist
Long term toxicity/cardiogenicity
often evaluated at the same time; small exposures over prolonged time; lifetime exposure (2 yr)
Reproductive toxicity
decreased fertility
teratogenicity
test for congenital malformations/fetal effects
Therapeutic index calculation
TD50/ED50 or MTC/MEC
Hazard
an inherent property - the potential of something to cause harm
Risk
probability of a particular adverse outcome
pharmacokinetic considerations
drug concentrations differ at target receptor, body weight, age, sex-related differences, pregnancy and lactation, health and disease
pharmacodynamic considerations
sex-related differences, circadian rhythms, drug tolerance, drug resistance
idiosyncrasy
an unexpected response or unexpected sensitivity to a drug that is frequently genetically based